TEL AVIV, Israel, June 27, 2024 /PRNewswire/ -- Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced it has joined Butterfly Garden, an artificial intelligence (AI) Marketplace launched by Butterfly Network, Inc. ('Butterfly') (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software..

以色列特拉维夫，2024年6月27日/PRNewswire/--今天，UltraSight，一家通过人工智能的力量改变心脏成像的数字健康先驱，宣布加入蝴蝶花园，这是一家由蝴蝶网络公司（“蝴蝶”）推出的人工智能（AI）市场（纽约证券交易所：BFLY），这是一家数字健康公司，通过便携式半导体超声技术和直观软件的力量来改变护理。。

UltraSight and Butterfly have partnered to increase patient access to cardiac care by enabling more healthcare professionals to perform cardiac ultrasound. Subject to regulatory approvals and authorizations, UltraSight aims to integrate and deploy its real-time AI guidance software on Butterfly's imaging platform and build the software for use with Butterfly's single-probe, whole-body handheld ultrasound system..

UltraSight和Butterfly合作，通过让更多的医疗保健专业人员进行心脏超声检查，增加患者获得心脏护理的机会。根据监管部门的批准和授权，UltraSight旨在将其实时AI指导软件集成并部署在蝴蝶的成像平台上，并构建该软件以与蝴蝶的单探头全身手持式超声波系统一起使用。。

Cardiovascular disease (CVD) is the leading global cause of death, accounting for an estimated 18 million deaths yearly. Today patients face significant delays in receiving crucial cardiac testing due to a fragmented market full of system bottlenecks, in addition to a national shortage of expert sonographers..

心血管疾病（CVD）是全球主要的死亡原因，估计每年有1800万人死亡。今天，由于充满系统瓶颈的零散市场以及全国缺乏专业超声医师，患者在接受关键心脏测试方面面临重大延误。。

UltraSight's mission is to empower any medical professional, including novice users with no prior sonography experience, to confidently conduct echocardiographic examinations and capture diagnostic quality cardiac ultrasound images at the point of care. Achieving compatibility with the most prominent handheld ultrasound device companies in the market, such as Butterfly, facilitates the company's goal of increasing access to cardiac care and reducing system bottlenecks for patients..

UltraSight的使命是授权任何医学专业人员，包括没有超声检查经验的新手用户，在护理点自信地进行超声心动图检查并捕获诊断质量的心脏超声图像。实现与市场上最著名的手持式超声波设备公司（如Butterfly）的兼容性，有助于该公司实现增加心脏护理机会和减少患者系统瓶颈的目标。。

'Joining the Butterfly Garden marks an important moment in our mission to revolutionize cardiac care,' said Davidi Vortman, CEO of UltraSight. 'By integrating our real-time AI guidance software with Butterfly's cutting-edge ultrasound technology, we are poised to transform the landscape of cardiac imaging.

UltraSight首席执行官大卫·沃特曼（DavidiVortman）说，加入蝴蝶园标志着我们彻底改变心脏护理使命的重要时刻通过将我们的实时人工智能引导软件与Butterfly的尖端超声技术相结合，我们准备改变心脏成像的格局。

This collaboration will empower healthcare professionals, regardless of their experience level, to perform accurate and timely cardiac ultrasound exams at the point of care. Together, we will break down existing barriers in cardiac care, ensuring that more patients receive the critical diagnostics they need, when and where they need it most.'.

这种合作将使医疗保健专业人员无论其经验水平如何，都能够在护理点进行准确及时的心脏超声检查。我们将共同打破现有的心脏护理障碍，确保更多患者在最需要的时间和地点获得他们所需的关键诊断。”。

'We are thrilled to partner with UltraSight to bring their AI guidance software to Butterfly devices in an effort to mitigate the pressing issue of sonographer shortages, among other workforce challenges, impacting medical communities around the world,' said Darius Shahida, chief strategy officer of Butterfly Network.

Butterfly Network首席战略官Darius Shahida说：“我们很高兴与UltraSight合作，将他们的人工智能指导软件带到Butterfly设备上，以缓解超声波仪短缺以及其他劳动力挑战等影响世界各地医疗界的紧迫问题。”。

'UltraSight and Butterfly are jointly dedicated to making healthcare more efficient, effective and accessible through high-quality ultrasound that's easy-to-use and globally available.'.

“UltraSight和Butterfly共同致力于通过易于使用且可在全球范围内获得的高质量超声波，使医疗保健更加高效，有效和方便。”。

In August 2023, Butterfly Network launched Butterfly Garden, allowing third-party developers access to its proprietary SDK and APIs to build new AI applications that work in conjunction with Butterfly's imaging platform, bringing with it access to the largest point-of-care ultrasound customer base. UltraSight, with capabilities to provide more medical professionals with the ability to take high-quality diagnostic images of the heart, has the potential to close the gap between novice and skilled Butterfly ultrasound users, and is an ideal match for the program. .

2023年8月，Butterfly Network推出了Butterfly Garden，允许第三方开发人员访问其专有的SDK和API，以构建与Butterfly的成像平台协同工作的新AI应用程序，从而访问最大的即时超声客户群。UltraSight能够为更多的医学专业人员提供拍摄高质量心脏诊断图像的能力，有可能缩小新手和熟练蝴蝶超声用户之间的差距，是该计划的理想选择。。

When paired with ultrasound devices, and following the appropriate regulatory clearance for each device, UltraSight's underlying AI neural network can predict the position of the ultrasound probe relative to the heart based on the ultrasound video stream and guide the user on maneuvering the probe to capture diagnostic quality cardiac images..

当与超声波设备配对并遵循每个设备的适当监管许可时，UltraSight的底层AI神经网络可以根据超声波视频流预测超声波探头相对于心脏的位置，并指导用户操纵探头以捕获诊断质量的心脏图像。。

UltraSight's partnership with Butterfly follows a series of recent collaborations with other industry leaders such as Mayo Clinic and EchoNous. For more information about UltraSight, visit www.ultrasight.com. For more information about Butterfly, visit www.butterflynetwork.com.

UltraSight与Butterfly的合作是在最近与梅奥诊所（MayoClinic）和回声（Echoous）等其他行业领导者进行了一系列合作之后进行的。有关UltraSight的更多信息，请访问www.UltraSight.com。有关蝴蝶的更多信息，请访问www.butterflynetwork.com。

About UltraSight

关于UltraSight

UltraSight's mission is to make diagnostic imaging more accessible by empowering medical professionals to successfully acquire timely and accurate cardiac ultrasound images anywhere. UltraSight's AI-driven software offers real-time guidance, making cardiac ultrasound accessible and efficient, which may lead to quicker diagnoses and improved patient care.

。UltraSight的人工智能驱动软件提供实时指导，使心脏超声变得可访问且高效，这可能会导致更快的诊断和改善患者护理。

In 2022, UltraSight won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most 'innovative cardiac technology.' Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. UltraSight's software has FDA 510(k) Clearance, is UKCA and CE Marked, and has Israeli AMAR Clearance to assist medical professionals in performing cardiac ultrasound scans.

2022年，UltraSight赢得了百时美施贵宝改善心血管疾病结局挑战赛，成为最“创新的心脏技术”此外，该公司还获得了超声设备实时引导解决方案的专利。UltraSight的软件已获得FDA 510（k）许可，带有UKCA和CE标志，并已获得以色列AMAR许可，以帮助医疗专业人员进行心脏超声扫描。

About Butterfly Network

关于Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission  to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound.

蝴蝶网络（Butterfly Network）由乔纳森·罗斯伯格（Jonathan Rothberg）博士于2011年成立，是一家数字健康公司，其使命是通过提供价格合理、易于使用、全球可访问且智能连接的高质量超声波，使医疗成像民主化，包括为全球47亿无法使用超声波的人提供超声波。

Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore's Law, to launch its second-generation Butterfly iQ+ in 2020, and third-generation iQ3 in 2024 – each with increased processing power and performance enhancements.

Butterfly利用半导体技术创建了世界上第一个手持式单探头全身超声波系统Butterfly iQ。该公司利用摩尔定律的优势，不断创新，于2020年推出第二代Butterfly iQ+，并于2024年推出第三代iQ3，每一代都具有更高的处理能力和性能增强。

The disruptive technology has been recognized by TIME's Best Inventions, Fast Company's World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world.

这项颠覆性技术已获得《时代》最佳发明奖、Fast公司改变世界的理念奖、CNBC Disruptor 50奖和MedTech突破奖等荣誉。凭借其专有的超声波芯片技术、智能软件和教育产品，Butterfly正在为超声波在全球范围内的早期检测和远程管理铺平道路。

Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country..

蝶形装置可在非洲、亚洲、澳大利亚、欧洲、中东、北美和南美部分地区的训练有素的医疗保健从业人员那里买到；要了解有关可用国家的更多信息，请访问：www.butterflynetwork.com/choose your country。。